Karthik Musunuri is the founder and Chief Executive Officer of Advaite. Karthik’s experience in big pharma includes R&D clinical development at GSK where he successfully managed late-stage Phase II/III clinical studies within the respiratory and immunoinflammatory therapeutic areas, and played a key role in the data analysis of the TRELEGY Phase III study. He also held a commercial role within vaccines at GSK, recognized by senior leadership as a top performer who contributed to the Shingrix® manufacturing and supply strategy. He also held a commercial role of increasing responsibility at Merck within chronic care, managing a top 5 revenue-generating territory for the multi-billion dollar chronic care franchise and leading the northeast in sales performance targets. In addition, Karthik worked at LexisNexis and QuintilesIMS in market research and risk analyses and handled numerous projects within the life sciences and healthcare space.
Current role